» Articles » PMID: 35986119

The Association Between Peripheral Arterial Disease and Risk for Hip Fractures in Elderly Men is Not Explained by Low Hip Bone Mineral Density. Results from the MrOS Sweden Study

Overview
Journal Osteoporos Int
Date 2022 Aug 19
PMID 35986119
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: To examine if peripheral arterial disease (PAD) is associated with an increased risk for hip fracture in men independent of hip BMD.

Methods: Ankle-brachial index (ABI) was assessed in the Swedish MrOS (Osteoporotic Fractures in Men) study, a prospective observational study including 3014 men aged 69-81 years at baseline. PAD was defined as ABI < 0.90. Incident fractures were assessed in computerized X-ray archives. The risk for hip fractures was calculated using Cox proportional hazard models. At baseline, BMD was assessed using DXA (Lunar Prodigy and Hologic QDR 4500) and functional measurements and blood samples were collected. Standardized questionnaires were used to collect information about medical history, falls, and medication.

Results: During 10 years of follow-up, 186 men had an incident hip fracture. The hazard ratio (HR) for hip fracture in men with PAD was 1.70 (95% CI 1.14-2.54), adjusted for age and study site. Additional adjustment for total hip BMD marginally affected this association (HR 1.64; 95% CI 1.10-2.45). In a final multivariate model, the HR attenuated to a non-significant HR 1.38 (95% CI 0.91-2.11) adjusted for age, site, hip BMD, BMI, falls, smoking, eGFR, handgrip strength, walking speed, former hip fracture, antihypertensive treatment, diabetes, education, and history of cardiovascular disease.

Conclusion: This study suggests that PAD is associated with an increased risk for hip fracture independently of hip BMD in elderly Swedish men. However, the high frequency of comorbidity and lower physical performance among men with PAD might partly explain this association.

Citing Articles

Random forest predictive modeling of prolonged hospital length of stay in elderly hip fracture patients.

Liu H, Xing F, Jiang J, Chen Z, Xiang Z, Duan X Front Med (Lausanne). 2024; 11:1362153.

PMID: 38828234 PMC: 11140010. DOI: 10.3389/fmed.2024.1362153.


FRAX predicts cardiovascular risk in women undergoing osteoporosis screening: the Manitoba bone mineral density registry.

Ye C, Schousboe J, Morin S, Lix L, McCloskey E, Johansson H J Bone Miner Res. 2024; 39(1):30-38.

PMID: 38630880 PMC: 11207923. DOI: 10.1093/jbmr/zjad010.

References
1.
Navas-Acien A, Selvin E, Sharrett A, Calderon-Aranda E, Silbergeld E, Guallar E . Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation. 2004; 109(25):3196-201. DOI: 10.1161/01.CIR.0000130848.18636.B2. View

2.
Moayeri A, Mohamadpour M, Mousavi S, Shirzadpour E, Mohamadpour S, Amraei M . Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis. Ther Clin Risk Manag. 2017; 13:455-468. PMC: 5395277. DOI: 10.2147/TCRM.S131945. View

3.
Shanbhogue V, Hansen S, Frost M, Brixen K, Hermann A . Bone disease in diabetes: another manifestation of microvascular disease?. Lancet Diabetes Endocrinol. 2017; 5(10):827-838. DOI: 10.1016/S2213-8587(17)30134-1. View

4.
McDermott M, Greenland P, Liu K, Guralnik J, Criqui M, Dolan N . Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment. JAMA. 2001; 286(13):1599-606. DOI: 10.1001/jama.286.13.1599. View

5.
Liu F, Lin C, Yeh C, Shih C, Cherng Y, Wu C . Risk and outcomes of fracture in peripheral arterial disease patients: two nationwide cohort studies. Osteoporos Int. 2017; 28(11):3123-3133. DOI: 10.1007/s00198-017-4192-z. View